近日，一家致力于生物技术的大型语言模型初创公司Bioptimus，在成立短短几个月后，成功筹集到了3500万美元的种子轮资金。本轮融资由法国生命科学风投公司Sofinnova Partners和公共银行Bpifrance Large Ventures领投，法国风险投资公司Frst和Cathay Innovation、美国投资者Headline、Owkin以及亿万富翁企业家Xavier Niel也参与了本轮融资。
Bioptimus公司计划利用这次筹集的资金，进一步研究和开发人工智能在生物技术领域的应用。据悉，该公司旨在为生物技术建立一个大型语言模型，以推动该领域的发展和创新。
作为一家初创公司，Bioptimus能获得如此高的投资，证明了其潜力和发展前景得到了业界的广泛认可。此次融资的成功，也将助力Bioptimus在生物技术领域的研究和应用，为该领域的发展带来新的机遇。
英文标题：AI Biotech Startup Bioptimus Secures $35 Million in Seed Funding
Keywords: AI Biotech, Investment, Bioptimus
News content:
Recently, Bioptimus, a startup focusing on the development of a large-scale language model in the field of biotechnology, has successfully raised $35 million in seed funding just a few months after its establishment. This round of financing was led by Sofinnova Partners, a French life science venture capital firm, and Bpifrance Large Ventures, a public bank. Other participants include French venture capital firm Frst and Cathay Innovation, American investors Headline and Owkin, and billionaire entrepreneur Xavier Niel.
Bioptimus plans to use the funds raised to further research and develop the application of artificial intelligence in the field of biotechnology. It is reported that the company aims to build a large-scale language model for biotechnology to promote the development and innovation in the field.
The substantial investment in Bioptimus, as a startup, demonstrates widespread recognition of its potential and development prospects in the industry. The success of this round of financing will also help Bioptimus in its research and application in the field of biotechnology, bringing new opportunities for the development of the field.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 1